MET and colorectal carcinoma: In conclusion, CCL19 plays an important role in angiogenesis inhibition by activating miR-206 expression and subsequently inhibiting Met/ERK/Elk-1/HIF-1α/VEGF-A signaling axis in CRC microenvironment.